{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-114042","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2026-10-06T20:05:29+00:00","discovered_at":"2026-10-06T20:06:01.251823+00:00","generated_at":"2026-10-12T16:22:00.802408+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"TELA Bio regains Nasdaq minimum bid price compliance; listing matter closed","bullets":["Nasdaq letter dated October 5, 2026 states TELA Bio regained compliance with Nasdaq Listing Rule 5450(a)(1), the minimum bid price requirement for the Nasdaq Global Market; matter is now closed.","Company's common stock continues to be listed and traded on the Nasdaq Global Market under the symbol 'TELA'.","Filing signed by Heather Getz, Chief Executive Officer and Director, dated October 6, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-114042","json":"https://secwatch.observer/filing/0001104659-26-114042.json","markdown":"https://secwatch.observer/filing/0001104659-26-114042.md","text":"https://secwatch.observer/filing/0001104659-26-114042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465926114042/0001104659-26-114042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465926114042/tm2627116d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:22:00.802408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}